Ep-CAM(上皮特異抗原)

廣州健侖生物科技有限公司

MOC抗體是一組可以與不同肺癌相關(guān)抗原同位素反應(yīng)的抗體。它們可以分為兩組，*組包括 MOC-1, MOC-21, MOC-32 和MOC-52。它們會(huì)優(yōu)先與肺小細(xì)胞（SCLC）和良性腫瘤反應(yīng)。據(jù)報(bào)道，它們能夠檢測(cè)冷凍組織切片。第二組是 MOC31。它能夠與各種各樣的肺癌反應(yīng)，包括SCLC。但它在正常的和惡性的間皮細(xì)胞不表達(dá)，可用于腺癌與間皮瘤的研究。干細(xì)胞可以轉(zhuǎn)變?yōu)槿魏晤愋偷募?xì)胞，科學(xué)家們一直渴望把這種“超能力”利用起來(lái)。不過(guò)，這種“超能力”在癌癥治療中又是一個(gè)令人擔(dān)憂的問(wèn)題。人們認(rèn)為，惡性腫瘤中的干細(xì)胞能幫助癌癥抵抗治療。zui近一項(xiàng)新研究表明，癌癥干細(xì)胞的威脅超乎人們的想象。
在此之前，人們只在快速生長(zhǎng)的侵襲性腫瘤中鑒定到干細(xì)胞。但華盛頓大學(xué)的研究團(tuán)隊(duì)在小鼠模型中發(fā)現(xiàn)，緩慢生長(zhǎng)的腫瘤也擁有令人頭疼的干細(xì)胞。而且這些低級(jí)別癌癥干細(xì)胞對(duì)抗癌藥物很不敏感，這項(xiàng)研究發(fā)表在三月十二日的Cell Reports雜志上。

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

歡迎咨詢

歡迎咨詢

Ep-CAM(上皮特異抗原)

【產(chǎn)品介紹】

細(xì)胞定位：細(xì)胞漿/細(xì)胞膜

克隆號(hào)：MOC-31

同型：IgG1/K

適用組織：石蠟/冰凍

陽(yáng)性對(duì)照：直腸癌/肺腺癌

抗原修復(fù)：熱修復(fù)（EDTA）

抗體孵育時(shí)間：30-60min

Ep-CAM(上皮特異抗原)

想了解更多的產(chǎn)品及服務(wù)請(qǐng)掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場(chǎng)部】     歐

【】 
【騰訊  】 
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-103室

MOC antibodies are a group of antibodies that react isotopely with different lung cancer-associated antigens. They can be divided into two groups, the first including MOC-1, MOC-21, MOC-32 and MOC-52. They preferentially respond to pulmonary small cells (SCLC) and benign tumors. It is reported that they can detect frozen tissue sections. The second group is MOC31. It can react with a wide variety of lung cancers, including SCLC. But it is not expressed in normal and malignant mesothelial cells and can be used in the study of adenocarcinoma and mesothelioma. Stem cells can be transformed into any type of cell, scientists have been eager to use this "super power." However, this "super power" is another worry in cancer treatment. It is believed that stem cells in malignancies can help treat cancer resistance. A recent new study shows that the threat of cancer stem cells beyond the imagination of people.
Previously, stem cells were identified only in rapidly growing aggressive tumors. But a team from the University of Washington found in the mouse model that slow-growing tumors also have troublesome stem cells. And these low-grade cancer stem cells are not sensitive to anticancer drugs, the study was published in the March 12 issue of Cell Reports.